Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of intravesical cyclosporine in severe interstitial cystitis/bladder pain syndrome
2015-004495-30Phase 2Completed
- Sponsor
- Oulu University Hospital
- Start
- Oct 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclosporine in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS), sponsored by Oulu University Hospital. Primary endpoint: Greatest safe intravesical cyclosporine dose. Started Oct 2015; status: completed.
02
Drugs
cyclosporine
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on 2015-004495-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004495-30.